The predictive role of ERCC1 status in oxaliplatin based neoadjuvant treatment for metastatic colorectal cancer (mCRC) to the liver

被引：0
|
作者：
Geva, Ravit
Shamai, Sivan
Barazovsky, Eli
Ben-Haim, Mend
Shmueli, Einat
机构：
来源：
TUMOR BIOLOGY | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] Genetic variants of Pint to predict benefit from irinotecan and oxaliplatin based treatment in patients with metastatic colorectal cancer (mCRC).
    Suenaga, Mitsukuni
    Schirripa, Marta
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Berger, Martin D.
    West, Jordan David
    Cremolini, Chiara
    Lonardi, Sara
    Battaglin, Francesca
    Ning, Yan
    Horiike, Yuki
    Yamamoto, Noriko
    Okazaki, Satoshi
    Miyamoto, Yuji
    Hanna, Diana L.
    Barzi, Afsaneh
    Loupakis, Fotios
    Falcone, Alfredo
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [32] ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
    Baek, Moo-Jun
    [J]. ANNALS OF COLOPROCTOLOGY, 2015, 31 (03) : 81 - 81
  • [33] Predictive and Prognostic Markers in the Treatment of Metastatic Colorectal Cancer (mCRC): Personalized Medicine at Work
    Stintzing, Sebastian
    Stremitzer, Stefan
    Sebio, Ana
    Lenz, Heinz-Josef
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (01) : 43 - +
  • [34] Co-expression of ERCC1 and Snail is a prognostic but not predictive factor of cisplatin-based neoadjuvant chemotherapy for bladder cancer
    Kawashima, Atsunari
    Takayama, Hitoshi
    Kawamura, Norihiko
    Doi, Noriteru
    Sato, Mototaka
    Hatano, Koji
    Nagahara, Akira
    Uemura, Motohide
    Nakai, Yasutomo
    Nishimura, Kensaku
    Miyoshi, Susumu
    Kawano, Kiyoshi
    Nishimura, Kazuo
    Nonomura, Norio
    Tsujimura, Akira
    [J]. ONCOLOGY LETTERS, 2012, 4 (01) : 15 - 21
  • [35] A prospective study of oxaliplatin and capecitabine (CapOx) in metastatic colorectal cancer (MCRC) with baseline stratification according to resectability status
    Watkins, D. J.
    Jackson, C.
    Chua, Y.
    Chong, G.
    Norman, A. R.
    Brown, G.
    Mudan, S.
    Karanjia, N.
    Cunningham, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Gene expression markers of resistance to capecitabine-oxaliplatin-bevacizumab treatment in metastatic colorectal cancer (mCRC).
    Rodriguez, Nuria
    Cejas, Paloma
    Moreno, Juan
    Mendiola, Marta
    Salud, Antonieta
    Jose Safont, Maria
    Garcia-Giron, Carlos
    Aparicio, Jorge
    Vera, Ruth
    Jorge Fernandez, Monica
    Escudero, Pilar
    Maurel, Juan
    Feliu, Jaime
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer
    Viguier, J
    Boige, V
    Miquel, C
    Pocard, M
    Giraudeau, B
    Sabourin, JC
    Ducreux, M
    Sarasin, A
    Praz, F
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6212 - 6217
  • [38] New biomarkers to predict response to oxaliplatin-based chemotherapy in metastatic colorectal cancer: KRAS and ERCC1.
    Strippoli, Antonia
    Basso, Michele
    Orlandi, Armando
    Schinzari, Giovanni
    Calegari, Alessandra
    Cursio, Olga Elisabetta
    Barile, Rosalba
    Amoruso, Alessia
    Pozzo, Carmelo
    Cassano, Alessandra
    Barone, Carlo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [39] XPD, XPA, ERCC1 and XPG/ERCC5 single nucleotide polymorphisms (SNPs) in oxaliplatin-treated colorectal cancer (CRC).
    Vila, JM
    Moreno, I
    Monzo, M
    Ibeas, R
    Moreno, J
    Pinuaga, M
    Martinez, F
    Navarro, A
    Pou, E
    Monne, JS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 288S - 288S
  • [40] XPA, XPD, ERCC1 and XPG/ERCC5 single nucleotide polymorphisme (SNPs) in oxaliplatin-treated colorectal cancer (CRC)
    Moreno-Solorzano, I.
    Monzo-Planella, M.
    Ibeas-Rollan, R.
    Navarro, A.
    Artells, R.
    Gel-Moreno, B.
    Moreno-Solorzano, J.
    Hernandez-Borlan, R.
    Etxaniz, O.
    Tello, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 253 - 253
12345